Distinct Clinical Implications of Patient‐ Versus Clinician‐Rated Motor Symptoms in Parkinson's Disease
Movement Disorders · 2024
DOI: 10.1002/mds.29962 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Movement Disorders, 2024. Verfasst von Akihiro Kikuya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Science and Technology Agency, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background
Patient‐rated motor symptoms (PRMS) and clinician‐rated motor symptoms (CRMS) often differ in Parkinson's disease (PD).
Objective
Our goal was to investigate the determinants and clinical implications of PRMS compared with CRMS in PD.
Methods
This retrospective, observational cohort study analyzed the cross‐sectional associations and longitudinal impacts of PRMS as assessed by the Movement Disorders Society‐sponsored Unified PD Rating Scale (MDS‐UPDRS) part 2, while controlling for CRMS measured by MDS‐UPDRS part 3. Longitudinal analyses used Cox proportional hazards models and multiple linear mixed‐effects random intercepts/slope models, adjusting for many clinical predictors. We conducted propensity score matching (PSM) to reinforce our analyses' robustness and surface‐based morphometry to investigate neural correlates.
Results
We enrolled 442 patients with early‐stage PD. At baseline, regardless of CRMS, PRMS were associated with the severity of postural instability and gait disturbance (PIGD). Notably, PRMS independently and more accurately predicted faster long‐term deterioration in motor function than CRMS (Hoehn and Yahr 4, adjusted hazard ratio per +1 point = 1.19 [95% confidence intervals, 1.08–1.32]), particularly in PIGD (PIGD subscore, β‐interaction = 0.052 [95% confidence intervals, 0.018–0.086]). PSM confirmed these findings' robustness. Surface‐based morphometry suggested that enhanced sensory processing was distinctively associated with PRMS.
Conclusions
In early‐stage PD, PRMS weighed different aspects of symptoms and more effectively predicted motor deterioration compared to CRMS, with distinctive brain structural characteristics. The superior sensitivity of PRMS to subtle declines in drug‐refractory symptoms like PIGD likely underlie our results, highlighting the importance of understanding the differential clinical implications of PRMS to prevent long‐term motor deterioration. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Advanced Comprehensive Research Organization, Teikyo University, Tokyo, Japan.
- Division of Sleep Medicine, Kansai Electric Power Medical Research Institute, Osaka, Japan.
- Department of Neurology, Osaka City General Hospital, Osaka, Japan.
ORCID-Profile: Kazuto Tsukita, Masanori Sawamura, Kenji Yoshimura, Ryosuke Takahashi
Förderung
- Japan Science and Technology Agency
- Japan Society for the Promotion of Science
Zitieren
APA
Kikuya, A., Tsukita, K., Sawamura, M., Yoshimura, K., & Takahashi, R. (2024). Distinct Clinical Implications of Patient‐ Versus Clinician‐Rated Motor Symptoms in Parkinson's Disease. Movement Disorders. https://doi.org/10.1002/mds.29962
Vancouver
Kikuya A, Tsukita K, Sawamura M, Yoshimura K, Takahashi R. Distinct Clinical Implications of Patient‐ Versus Clinician‐Rated Motor Symptoms in Parkinson's Disease. Movement Disorders. 2024. doi:10.1002/mds.29962
BibTeX
@article{Kikuya2024,
author = {Kikuya, Akihiro and Tsukita, Kazuto and Sawamura, Masanori and Yoshimura, Kenji and Takahashi, Ryosuke},
title = {Distinct Clinical Implications of Patient‐ Versus Clinician‐Rated Motor Symptoms in Parkinson's Disease},
journal = {Movement Disorders},
year = {2024},
doi = {10.1002/mds.29962}
}
EUVIMED